Jaguar Health Partners with B2i Digital for Innovative Investor Engagement Campaign

Developing First-In-Class Plant-based Medicines for GI Disease

Jaguar Health, Inc. (Nasdaq: JAGX) and its family company Napo Pharmaceuticals (Napo) is a commercial-stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with GI distress, specifically overactive bowel, which includes symptoms such as chronic debilitating diarrhea, GI urgency, and GI incontinence.